FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Tramadol Hydrochloride (Ultram) Tablets
Status: Discontinuation
»Therapeutic Categories: Analgesia/Addiction

Janssen Pharmaceuticals (New 04/01/2020)

Company Contact Information:

Presentation Posting Date Related Information
50 mg/1 unit (NDC 50458-659-60) 04/01/2020 The Company has made a business decision to permanently discontinue Ultram tablets. Product should be maintained on the formularies until the last batch produced expires (30 Sept 2022), in order to maintain continuity of the reimbursement process.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English